Skip to main content
Top
Published in: Clinical Rheumatology 5/2016

01-05-2016 | Original Article

Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

Authors: Lourdes Mateo, Susana Holgado, Maria Luisa Mariñoso, Ricard Pérez-Andrés, Anna Bonjoch, Joan Romeu, Alejandro Olivé

Published in: Clinical Rheumatology | Issue 5/2016

Login to get access

Abstract

Tenofovir disoproxil fumarate (TDF) is an adenine analogue reverse transcription inhibitor widely used in first-line treatment of human immunodeficiency virus (HIV) infection and also in hepatitis B virus infection. Its use has been linked to sporadic Fanconi syndrome, renal failure and bone disease. We present the clinical characteristics of tenofovir-induced osteomalacia, discuss bone biopsy findings, describe predisposing factors and compare our results with other reported cases. We describe five cases of hypophosphatemic osteomalacia induced by TDF and recorded at the rheumatology service of a university hospital between 2010 and 2014. We also report the characteristics of bone biopsies of this pathology, which have not been previously described. We include a review of published cases of proximal renal tubulopathy (PRT) and osteomalacia induced by TDF (PubMed 1995–2014; keywords: osteomalacia, tenofovir, Fanconi syndrome, hypophosphatemic osteomalacia, proximal renal tubulopathy, bone biopsy). Five HIV patients who developed hypophosphatemic osteomalacia under TDF treatment (>5 years) presented increasing bone pain and a progressive inability to walk without assistance as a result of multiple insufficiency fractures. Bone biopsy performed in three patients after tetracycline labelling showed increased osteoid thickness, confirming osteomalacia. A literature review retrieved 17 publications on this condition, including 53 cases: 26 patients developed isolated PRT, 25 presented PRT and with multiple insufficiency fractures and two presented isolated bone disease, including osteomalacia and osteoporosis. Rheumatologists should be alert to this complication in patients receiving tenofovir. The main complaint reported by these patients is diffuse pain, predominantly in the lower limbs, indicating multiple stress fractures. Serum phosphate and appropriate screening for abnormal proximal tubule function should be monitored. Bone scintigraphy should be carried out in cases of limb pain before the occurrence of more severe complications.
Literature
1.
go back to reference Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17(13):1917–1923CrossRefPubMed Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17(13):1917–1923CrossRefPubMed
2.
go back to reference Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20(17):2165–2174CrossRefPubMed Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20(17):2165–2174CrossRefPubMed
3.
go back to reference Cotter AG, Powderly WG (2011) Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. Best Pract Res Clin Endocrinol Metab 25(3):501–515CrossRefPubMed Cotter AG, Powderly WG (2011) Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. Best Pract Res Clin Endocrinol Metab 25(3):501–515CrossRefPubMed
4.
go back to reference Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L et al (2010) High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 24(18):2827–2833CrossRefPubMed Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L et al (2010) High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 24(18):2827–2833CrossRefPubMed
5.
go back to reference Izzedine H, Hulot JS, Vittecoq D, Gallant JE, Staszewski S, Launay-Vacher V et al (2005) Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 20(4):743–746CrossRefPubMed Izzedine H, Hulot JS, Vittecoq D, Gallant JE, Staszewski S, Launay-Vacher V et al (2005) Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 20(4):743–746CrossRefPubMed
6.
go back to reference Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G (2006) Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis 42(2):283–290CrossRefPubMed Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G (2006) Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis 42(2):283–290CrossRefPubMed
7.
go back to reference Saidenberg-Kermanac’h N, Souabni L, Prendki V, Prie D, Boissier MC (2011) Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. Joint Bone Spine 78(3):306–308CrossRefPubMed Saidenberg-Kermanac’h N, Souabni L, Prendki V, Prie D, Boissier MC (2011) Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. Joint Bone Spine 78(3):306–308CrossRefPubMed
8.
go back to reference Haverkort ME, van der Spek BW, Lips P, Slieker WA, ter Heine R, Huitema AD et al (2011) Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature. Scand J Infect Dis 43(10):821–826CrossRefPubMed Haverkort ME, van der Spek BW, Lips P, Slieker WA, ter Heine R, Huitema AD et al (2011) Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature. Scand J Infect Dis 43(10):821–826CrossRefPubMed
9.
go back to reference Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J et al (2009) Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS 23(6):689–696CrossRefPubMed Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J et al (2009) Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS 23(6):689–696CrossRefPubMed
10.
go back to reference Kinai E, Hanabusa H (2009) Progressive renal tubular dysfunction associated with long-term use of tenofovir DF. AIDS Res Hum Retrovir 25(4):387–394CrossRefPubMed Kinai E, Hanabusa H (2009) Progressive renal tubular dysfunction associated with long-term use of tenofovir DF. AIDS Res Hum Retrovir 25(4):387–394CrossRefPubMed
11.
go back to reference Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD et al (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 292(2):191–201CrossRefPubMed Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD et al (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 292(2):191–201CrossRefPubMed
12.
go back to reference Coca S, Perazella MA (2002) Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity. Am J Med Sci 324(6):342–344CrossRefPubMed Coca S, Perazella MA (2002) Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity. Am J Med Sci 324(6):342–344CrossRefPubMed
13.
go back to reference Woodward CL, Hall AM, Williams IG, Madge S, Copas A, Nair D et al (2009) Tenofovir-associated renal and bone toxicity. HIV Med 10(8):482–487CrossRefPubMed Woodward CL, Hall AM, Williams IG, Madge S, Copas A, Nair D et al (2009) Tenofovir-associated renal and bone toxicity. HIV Med 10(8):482–487CrossRefPubMed
14.
go back to reference Peyriere H, Reynes J, Rouanet I, Daniel N, de Boever CM, Mauboussin JM et al (2004) Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr 35(3):269–273CrossRefPubMed Peyriere H, Reynes J, Rouanet I, Daniel N, de Boever CM, Mauboussin JM et al (2004) Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr 35(3):269–273CrossRefPubMed
15.
go back to reference Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK et al (2004) Renal safety of tenofovir in HIV treatment-experienced patients. AIDS 18(7):1074–1076CrossRefPubMed Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK et al (2004) Renal safety of tenofovir in HIV treatment-experienced patients. AIDS 18(7):1074–1076CrossRefPubMed
16.
go back to reference Jhaveri MA, Mawad HW, Thornton AC, Mullen NW, Greenberg RN (2010) Tenofovir-associated severe bone pain: I cannot walk! J Int Assoc Phys AIDS Care (Chic) 9(5):328–334CrossRef Jhaveri MA, Mawad HW, Thornton AC, Mullen NW, Greenberg RN (2010) Tenofovir-associated severe bone pain: I cannot walk! J Int Assoc Phys AIDS Care (Chic) 9(5):328–334CrossRef
17.
go back to reference Perrot S, Aslangul E, Szwebel T, Caillat-Vigneron N, Le Jeunne C (2009) Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient. J Clin Rheumatol 15(2):72–74CrossRefPubMed Perrot S, Aslangul E, Szwebel T, Caillat-Vigneron N, Le Jeunne C (2009) Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient. J Clin Rheumatol 15(2):72–74CrossRefPubMed
18.
go back to reference Gutmann H, Fricker G, Drewe J, Toeroek M, Miller DS (1999) Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol 56(2):383–389PubMed Gutmann H, Fricker G, Drewe J, Toeroek M, Miller DS (1999) Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol 56(2):383–389PubMed
19.
go back to reference Bonjoch A, Echeverria P, Perez-Alvarez N, Puig J, Estany C, Clotet B et al (2012) High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy. Antiviral Res 96(1):65–69CrossRefPubMed Bonjoch A, Echeverria P, Perez-Alvarez N, Puig J, Estany C, Clotet B et al (2012) High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy. Antiviral Res 96(1):65–69CrossRefPubMed
20.
go back to reference Earle KE, Seneviratne T, Shaker J, Shoback D (2004) Fanconi’s syndrome in HIV + adults: report of three cases and literature review. J Bone Miner Res 19(5):714–721CrossRefPubMed Earle KE, Seneviratne T, Shaker J, Shoback D (2004) Fanconi’s syndrome in HIV + adults: report of three cases and literature review. J Bone Miner Res 19(5):714–721CrossRefPubMed
21.
go back to reference Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW (2005) The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 6(5):341–346CrossRefPubMed Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW (2005) The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 6(5):341–346CrossRefPubMed
22.
go back to reference De la Prada FJ, Prados AM, Tugores A, Uriol M, Saus C, Morey A (2006) Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir. Nefrologia 26(5):626–630PubMed De la Prada FJ, Prados AM, Tugores A, Uriol M, Saus C, Morey A (2006) Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir. Nefrologia 26(5):626–630PubMed
23.
go back to reference Torres Isidro MV, Garcia Benayas T, del Val Gomez Martinez M, Gonzalez Gallardo F, Gambi Pisonero N, Castilla Miguel S et al (2006) Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir. Rev Esp Med Nucl 25(2):103–106CrossRefPubMed Torres Isidro MV, Garcia Benayas T, del Val Gomez Martinez M, Gonzalez Gallardo F, Gambi Pisonero N, Castilla Miguel S et al (2006) Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir. Rev Esp Med Nucl 25(2):103–106CrossRefPubMed
24.
go back to reference Rosello L, Gort A, Planella R, Cabau J (2007) Hypophosphatemia and multiple fractures in patient with human immunodeficiency virus infection treated with tenofovir. Med Clin (Barc) 129(5):197CrossRef Rosello L, Gort A, Planella R, Cabau J (2007) Hypophosphatemia and multiple fractures in patient with human immunodeficiency virus infection treated with tenofovir. Med Clin (Barc) 129(5):197CrossRef
25.
go back to reference Brim NM, Cu-Uvin S, Hu SL, O’Bell JW (2007) Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome. AIDS Read 17(6):322–328, C3PubMed Brim NM, Cu-Uvin S, Hu SL, O’Bell JW (2007) Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome. AIDS Read 17(6):322–328, C3PubMed
26.
go back to reference Di Biagio A, Rosso R, Monteforte P, Russo R, Rovetta G, Viscoli C (2009) Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report. J Med Case Rep 3:8136CrossRefPubMedPubMedCentral Di Biagio A, Rosso R, Monteforte P, Russo R, Rovetta G, Viscoli C (2009) Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report. J Med Case Rep 3:8136CrossRefPubMedPubMedCentral
27.
go back to reference Wanner DP, Tyndall A, Walker UA (2009) Tenofovir-induced osteomalacia. Clin Exp Rheumatol 27(6):1001–1003PubMed Wanner DP, Tyndall A, Walker UA (2009) Tenofovir-induced osteomalacia. Clin Exp Rheumatol 27(6):1001–1003PubMed
28.
go back to reference Izzedine H, Thibault V, Valantin MA, Peytavin G, Schneider L, Benhamou Y (2010) Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence? AIDS 24(7):1078–1079CrossRefPubMed Izzedine H, Thibault V, Valantin MA, Peytavin G, Schneider L, Benhamou Y (2010) Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence? AIDS 24(7):1078–1079CrossRefPubMed
29.
go back to reference Perez-Rivera AA, Saez P, Leon E, Lozano de Leon-Naranjo F (2011) HIV infected women with intense bone and muscular pain and general weakness. Enferm Infecc Microbiol Clin 29(4):308–310CrossRefPubMed Perez-Rivera AA, Saez P, Leon E, Lozano de Leon-Naranjo F (2011) HIV infected women with intense bone and muscular pain and general weakness. Enferm Infecc Microbiol Clin 29(4):308–310CrossRefPubMed
30.
go back to reference De Socio GV, Fabbriciani G, Massarotti M, Messina S, Cecchini E, Marasini B (2012) Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required. Mediterr J Hematol Infect Dis 4(1):e2012025CrossRefPubMedPubMedCentral De Socio GV, Fabbriciani G, Massarotti M, Messina S, Cecchini E, Marasini B (2012) Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required. Mediterr J Hematol Infect Dis 4(1):e2012025CrossRefPubMedPubMedCentral
31.
go back to reference Lucey JM, Hsu P, Ziegler JB (2013) Tenofovir-related Fanconi’s syndrome and osteomalacia in a teenager with HIV. BMJ Case Rep 9:2013 Lucey JM, Hsu P, Ziegler JB (2013) Tenofovir-related Fanconi’s syndrome and osteomalacia in a teenager with HIV. BMJ Case Rep 9:2013
32.
go back to reference Koenig KF, Kalbermatter S, Menter T, Graber P, Kiss D (2014) Recurrent bone fractures due to tenofovir-induced renal phosphate wasting. Scand J Infect Dis 46(3):221–224CrossRefPubMed Koenig KF, Kalbermatter S, Menter T, Graber P, Kiss D (2014) Recurrent bone fractures due to tenofovir-induced renal phosphate wasting. Scand J Infect Dis 46(3):221–224CrossRefPubMed
33.
go back to reference Gómez Martinez MV, Gallardo FG, Pirogova T, García-Samaniego J (2014) Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir. Rev Esp Med Nucl Imagen Mol 33(2):103–105PubMed Gómez Martinez MV, Gallardo FG, Pirogova T, García-Samaniego J (2014) Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir. Rev Esp Med Nucl Imagen Mol 33(2):103–105PubMed
34.
35.
go back to reference Hall AM, Hendry BM, Nitsch D, Connolly JO (2011) Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 57(5):773–780CrossRefPubMed Hall AM, Hendry BM, Nitsch D, Connolly JO (2011) Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 57(5):773–780CrossRefPubMed
36.
go back to reference Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA et al (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40(11):1559–1585CrossRefPubMed Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA et al (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40(11):1559–1585CrossRefPubMed
Metadata
Title
Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients
Authors
Lourdes Mateo
Susana Holgado
Maria Luisa Mariñoso
Ricard Pérez-Andrés
Anna Bonjoch
Joan Romeu
Alejandro Olivé
Publication date
01-05-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2627-x

Other articles of this Issue 5/2016

Clinical Rheumatology 5/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.